Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of ECG-derived f-wave Indices from Implantable Loop Recorder: Analysis from the LOOP Study.

Heart rhythm·2026
Same author

Pregabalin-Induced Myoclonus in a Patient Without Kidney Dysfunction.

Case reports in neurological medicine·2026
Same author

Vascular Neurology Fellowship: Where Do We Go From Here?

Stroke·2026
Same author

The cost-effectiveness of implantable loop recorder detection of atrial fibrillation to prevent stroke in persons at high risk: An economic evaluation alongside a multicentre randomised controlled trial in Denmark (The LOOP Study).

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Exploring Sex Differences in Stroke Outcomes: A Comprehensive Analysis From the SPAN 1 Trial.

Journal of the American Heart Association·2026
Same author

Frequency of Thrombectomy in Early and Late Postonset Time Windows Among Emergency Medical Services Patients With Acute Ischemic Stroke.

Stroke (Hoboken, N.J.)·2026

Related Experiment Video

Updated: Jul 2, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Therapeutic hypothermia for acute stroke.

Patrick D Lyden1, Derk Krieger, Midori Yenari

  • 1Neurology and Research Services of the San Diego Veteran's Administration Medical Center, Department of Neurosciences, University of California, San Diego, CA, USA. plyden@ucsd.edu

International Journal of Stroke : Official Journal of the International Stroke Society
|August 19, 2008
PubMed
Summary

Therapeutic hypothermia shows promise for neuroprotection in stroke patients. Further Phase 1 and 2 trials are essential to confirm safety before large-scale efficacy studies.

More Related Videos

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Experiment Videos

Last Updated: Jul 2, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Critical Care Medicine

Background:

  • Hypothermia is a potent neuroprotective therapy, but its clinical application is hindered by technological and physiological challenges.
  • Advances in cooling technology and successful cardiac arrest trials have renewed interest in hypothermia for stroke treatment.
  • Previous neuroprotective therapies for stroke have largely failed, necessitating careful evaluation of new approaches.

Purpose of the Study:

  • To evaluate the potential of therapeutic hypothermia as a neuroprotective strategy for stroke patients.
  • To review preclinical and early clinical data on hypothermia for various indications, including stroke.
  • To identify key hypotheses for future clinical trials investigating hypothermia in stroke.

Main Methods:

  • Systematic review of preclinical studies on hypothermia's neuroprotective mechanisms.
  • Analysis of early-phase clinical trials involving hypothermia for cardiac arrest and other conditions.
  • Examination of technological and homeostatic challenges related to clinical hypothermia application.

Main Results:

  • Hypothermia demonstrates significant neuroprotective potential across various preclinical models.
  • Early clinical data suggest feasibility but highlight the need for optimized delivery and monitoring.
  • Existing technology and physiological mechanisms present challenges to sustained therapeutic hypothermia.

Conclusions:

  • Therapeutic hypothermia is a promising neuroprotective strategy for stroke.
  • Further Phase 1 and Phase 2 clinical development is required to establish safety and optimal protocols.
  • Definitive efficacy trials in stroke patients should be contingent upon successful completion of these safety and feasibility studies.